Compare ADMA Biologics Inc (ADMA) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Motorola Solutions Inc — how do they compare? ADMA Biologics Inc trades at $9.23 (market cap $2.13B), while Motorola Solutions Inc trades at $418.28 (market cap $70.42B). The key difference: Motorola Solutions Inc is far larger — about 33.1× ADMA Biologics Inc's market cap, and Motorola Solutions Inc pays a 1.14% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | MSI | |
|---|---|---|
Market Cap | $2.13B | $70.42B |
Sector | Health | Technology |
52-Week High | $20.38 | $490.30 |
52-Week Low | $7.60 | $363.83 |
Enterprise Value | $2.20B | $79.12B |
Dividend Yield | — | 1.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
Motorola Solutions (MSI) trades at $424.21, up 0.37% with strong technical momentum and bullish analyst sentiment. The company demonstrates robust fundamentals with 17.61% net margins and consistent earnings beats, supported by recent AI expansion initiatives and a $1.5B acquisition of D-Fend Solutions. Revenue growth has accelerated from $9.1B in 2022 to $11.7B in 2025.
MSI presents a compelling growth story with AI-driven public safety expansion and strong institutional support, though elevated valuation multiples and increased capital expenditures pose risks. The consensus price target of $512.33 suggests 21% upside potential, supported by 71% analyst buy ratings and positive technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
